Acelrx Pharmaceuticals

ACRX

2.05

+0.05

+2.5%

Please Login or Register

Login|Register FREE

Stock Price
Open: 2.03
Prev. Close: 2.00
Low/Hi: 2.00 - 2.05
52-Week: 1.55 - 5.75
Volumes
Equity: 77,218
90-Day Avg: 1,551,485
Option: 35
90-Day Avg: 994
Volatility
Todays Stock Vol: 27.7
20-Day (HV): 46.5
52-Week (HV): 72.1
30-Day IV: 57.7 +0.2
IV Pct Rank: 23% Subdued
Fundamental
Div. Yield:
Earnings: 6-Mar (Est.)
P/E Ratio:
Market Cap: 100.7 M
Short Int Pct: 0.0%
Pct Held By Inst.: 12.9%
Stock Info
Type: Common
Sector: Healthcare
Industry: Medical Appliances & Equipment

ACRX Company Events

Upcoming Events
Event Event Date Location Info
No Upcoming Events
Past Events
Event Event Date Location Info
ASA's Annual Meeting - ANESTHESIOLOGY 2017 DSUVIA clinical trial results Oct 21, 2017 - Oct 25, 2017
Cantor Fitzgerald Global Healthcare Conference Sep 26, 2017
Rodman & Renshaw 19th Annual Global Investment Conference Sep 11, 2017
ZALVISO Phase 3 Top-line Data and Quarterly Financial Results Aug 1, 8:30 AM
Jefferies 2017 Global Healthcare Conference Jun 7, 10:30 AM
CF&B European Smallcap Apr 19, 2017
American Society of Regional Anesthesia and Pain Medicine (ASRA) Apr 6, 2017 - Apr 8, 2017
MicroCap Conference Apr 4, 2017
Oppenheimer's 27th Annual Healthcare Conference Mar 22, 2017
International Symposium on Intensive Care and Emergency Medicine Mar 21, 12:00 AM
American Academy of Pain Medicine Mar 16, 2017
29th Annual ROTH Conference Mar 13, 5:30 PM
37th Annual Cowen Health Care Conference Mar 8, 10:00 AM
RBC Capital Markets 2017 Global Healthcare Conference Feb 22, 8:00 AM
Small Cap Nation Family Office & Life Science Symposium Feb 21, 2017
2017 Disruptive Growth & Healthcare Conference Feb 15, 8:30 AM
BIO CEO & Investor Conference Feb 14, 9:30 AM
Analyst & Investor Event Dec 1, 2016
Piper Jaffray Healthcare Conference Nov 29, 2016
Piper Jaffray Healthcare Conference Nov 29, 2016
Annual ASRA Pain Medicine Meeting Nov 17, 2016 - Nov 19, 2016
i

A Phase 3 Open Label Study of the Sufentanil Sublingual Tablet 30mcg for Treatment of Acute Post-Operative Pain

Jefferies London Healthcare Conference Nov 16, 2016
Mizuho Global Investor Conference Nov 14, 2016
Global Mizuho Investor Conference Nov 14, 2016
The Obesity Society Annual Meeting Oct 31, 2016 - Nov 4, 2016
i

This poster presents data that shows that obese patients treated with ARX-04 (sufentanil sublingual tablet, 30 mcg) in the Phase 3 SAP301 study following ambulatory abdominal surgery experienced greater pain relief over the 12-hour study period (SPID-12) compared to those treated with a placebo. The experience of obese patients in the study was similar to that of patients with lower BMIs. Nausea (23%) and headache (10%) were the only adverse events reported by more than one patient in the obese cohort treated with ARX-04. Overall, while sample sizes were limited, the conclusion of this analysis was that safety and efficacy results were consistent across the entire study population, regardless of BMI.

European Congress on Emergency Medicine (ECEM) Oct 1, 2016 - Oct 5, 2016
i

The first presentation summarizes the safety and efficacy findings from the Phase 3 SAP302 study of ARX-04 (sufentanil sublingual tablet, 30 mcg) in patients who were admitted to the emergency department with an injury or trauma associated with moderate-to-severe acute pain. Results from this trial showed substantial reductions in pain intensity (mean 2.9 out of 10 on a validated pain scale) within the first hour among the 76 patients treated with ARX-04. The second e-poster provides insights into the direct and indirect (labor, pharmacy, etc.) costs associated with the administration of intravenous (IV) opioids. Based on an analysis of over 600 hospitals, AcelRx has determined that an initial IV dose of an opioid, such as morphine, hydromorphone and fentanyl, ranges from $143 to $145 in U.S. emergency departments.

Sachs Biotech in Europe Forum Sep 28, 4:45 AM
Ladenburg Thalmann 2016 Healthcare Sep 27, 2016 Sofitel, New York
Ladenburg Thalmann Healthcare Conference Sep 27, 3:00 PM
Rodman & Renshaw Global Investment Conference Sep 13, 10:50 AM
Rodman & Renshaw Global Investment Conference Sep 11, 2016
Biocentury NewsMakers in the Biotech Industry Sep 9, 2016
BioCentury 23rd Annual NewsMakers Conference Sep 9, 2016 Millennium Hotel New York
7th World Congress of Mountain & Wilderness Medicine Jul 30, 2016 - Aug 4, 2016 the Telluride Conference Center in Telluride, Colorado
i

Company and its investigators will be presenting top-line results from the initial cohort of 40 patients in single-arm, open-label Phase3 SAP302 study, which assessed ARX-04 (sufentanil sublingual tablet, 30 mcg) as a treatment for moderate-to-severe acute pain in adults who presented to the emergency department with trauma or injury.

Cantor Fitzgerald 2nd Annual Healthcare Conference Jul 12, 2016 Le Parker Meridien, New York
3rd Annual ROTH Healthcare DayDate Jun 22, 2:30 PM The Dorchester, London
ROTH Healthcare Day Jun 22, 2016
AcelRx Pharmaceuticals Inc Annual Shareholders Meeting Jun 21, 3:00 PM
Jefferies 2016 Healthcare Conference Jun 9, 9:00 AM Grand Hyatt, New York
2016 BIO International Jun 9, 2016 Moscone Center, San Francisco
Biotechnology Industry Organization (BIO) International Convention Jun 9, 2:30 PM
Jefferies Healthcare Conference Jun 9, 9:00 AM
Euroanaesthesia 2016, May 28, 2016 - May 30, 12:15 AM London, UK
i

Company and its investigators will be presenting Phase 3 SAP301 study results

Bank of America Merrill Lynch Health Care Conference May 12, 1:40 PM
Bank of America Merrill Lynch 2016 Health Care ConferenceDate May 12, 2016 Encore at Wynn Las Veg
Biocentury BioEquity Europe May 11, 5:00 AM
BioEquity Europe Conference May 11, 2016 Copenhagen
EBD BIO-Europe Spring Conference Apr 5, 10:45 AM
AcelRx Pharmaceuticals Names Howard B. Rosen as Chief Executive Officer and Provides Update on Clinical Development Activities and Corporate Priorities for 2016 Corporate Call Mar 29, 2016
28th Annual ROTH Conference Mar 15, 2016
Cowen Health Care Conference Mar 9, 2016
2016 RBC Capital Markets' Healthcare Conference Feb 23, 2016 The New York Palace Hotel
i

Chief Financial Officer and Head of Business Development, Timothy E. Morris will be presenting

38th annual John A. Boswick, M.D. Burn and Wound Care Symposium Feb 14, 2016 - Feb 18, 2016 in Hawaii.
18th Annual BIO CEO & Investor Conference Feb 9, 1:00 PM The Waldorf Astoria New York
i

Chief Financial Officer and Head of Business Development, Timothy E. Morris will be presenting

2016 at the Disneyland Hotel New York Convention Centre in Paris, France Jan 29, 2016 Disneyland Hotel New York Convention Centre in Paris, France.
Announces Presentation of Phase 3 Sufentanil Sublingual 30 mcg Tablet (ARX-04) Data at the European Congress of Ambulatory Surgery Jan 29, 2016 Disneyland Hotel New York Convention Centre in Paris, France
Trout Group 1x1 Management Access Event Jan 11, 2016
Piper Jaffray 27th Annual Healthcare Conference Dec 1, 2015 New YorkNew York Palace Hotel, New York
i

AcelRx Co-founder and Chief Medical Officer Pamela Palmer and Chief Financial Officer Tim Morris will be presenting

Jefferies 2015 Global Healthcare Conference Nov 19, 5:20 PM The May Fair Hotel, London
i

Chief Financial Officer Tim Morris will be presenting

Credit Suisse 24th Annual Healthcare Conference Nov 11, 3:30 PM The Phoenician, Phoenix, AZ
i

Chief Financial Officer Tim Morris will be presenting

Emergency Medicine (EuSEM) meetin Oct 11, 2015 Lingotto Congress Centre in Turin, Italy
i

The annual EuSEM is the largest meeting of emergency medicine practitioners in the world with over 2000 delegates in attendance and 90 countries represented.

BioCentury NewsMakers Conference Sep 10, 2015 Millennium Broadway Hotel, New York
Rodman and Renshaw 17th Annual Global Investment Conference Sep 9, 2015 The St. Regis New York
Second Annual Healthcare Conference Sep 9, 2015 Four Seasons, Boston
UBS Global Healthcare Conference May 18, 2015
Bank of America Healthcare Conference 2015 May 12, 3:00 PM
Mizuho Third Annual Healthcare Corporate Access Day May 5, 2015
Annual Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) meeting Apr 15, 2015
American Society of Plastic Surgeons (ASPS).
i

Dr. Shankar Lakshman, a board-certified plastic surgeon and AcelRx clinical investigator, will present a subgroup analysis from the SAP301 study at the annual meeting.

Rodman & Renshaw 18th Annual Global Investment The Lotte New York Palace
2015 Annual Meeting of the American Society of Anesthesiologists (Anesthesiology 2015) San Diego Convention Center in San Diego, CA
i

The presentation marks the first time top-line results from the phase 3 study using sublingual sufentanil 30 mcg tablets being studied for the management of moderate-to-severe acute pain in outpatient abdominal surgery patients, or SAP301, will be revealed to an academic and scientific community within the U.S.

Society of Regional Anesthesia and Pain Medicine (ASRA) 14th Annual Pain Medicine Meeting
i

Palmer, M.D. Ph.D., AcelRx Co-founder and Chief Medical Officer, will present safety and efficacy data from a Phase 3 trial, SAP301, evaluating the sufentanil sublingual 30 mcg tablet, or ARX-04, for the treatment of acute pain following ambulatory surgery. A moderated poster presentation will be made

Wait, Before You Leave...

Want to Know More About ACRX Earnings?

Receive your FREE email to get Wall Street expected earnings moves and daily upcoming earnings alerts!
Market Chameleon